Avid Bioservices Inc (CDMO)

[jazzbeerman]

jake,

Agree. Response rate looks great, but the most important stat will be median progression-free survival, duration of response, etc.
They'll be seeing more clearly whether the Bavi patients beat Avastin after they've passed the 7 month mark. As patients pass that point in time, if more than half are still progression-free, that's big.

The first patient(s) were dosed around Feb 12th. It has now been 30 weeks, to the day, since feb 12th. The patients go OFF CHEMO after 6 four-week chemo cycles, (24 weeks). So some of the earliest treated patients are on just Bavi now, but we don't know if they've been scanned post-chemo yet. Now, at the 30 week point, the earliest patients dosed are just passing the point of Avastin median progression-free survival...

j